Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
BBPvsPSCHETF Comparison
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.29% for PSCH. BBP is up 5.62% year-to-date (YTD) with +$4M in YTD flows. PSCH performs worse with -9.57% YTD performance, and -$14M in YTD flows. Run a side-by-side ETF comparison of BBP and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBP vs PSCH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP PSCH | +2.73%-4.98% | +7.35%-13.47% | +5.62%-9.57% | +41.19%-4.84% | +72.79%-5.55% | +54.18%-37.27% |
| Flows | BBP PSCH | +$4M-$12M | +$16M-$15M | +$4M-$14M | +$19M-$33M | +$19M-$168M | +$9M-$230M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP PSCH | +24.64%+19.05% | +25.49%+23.19% | +23.37%+21.52% | +26.10%+22.79% |
| Max drawdown | BBP PSCH | -7.42%-13.93% | -17.97%-13.93% | -25.54%-23.50% | -38.24%-47.23% |
| Max drawdown duration | BBP PSCH | 32d80d | 106d80d | 292d449d | 915d1719d |
BBP | PSCH | |
Last sale 3/13/2026 at 1:30 PM | $81.25 | $39.79 |
| Previous close 03/12/2026 | $81.68 | $39.81 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | PSCH | |
|---|---|---|
| Last price | $81.25 | $39.79 |
| 1D performance | -0.53% | -0.05% |
| AuM | $50.55 M | $120.40 M |
| E/R | 0.79% | 0.29% |
BBP | PSCH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Products Index | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 58 | 71 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 7, 2010 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the BBP and PSCH ETFs performed in 2026?
As of March 11, 2026, BBP is up 5.62% year-to-date (YTD), while PSCH has lost -9.57%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or PSCH?
Year-to-date, the BBP ETF saw +$4M in flows, compared to -$14M for PSCH.
Which ETF is more volatile: BBP or PSCH?
Over the past year, BBP had a volatility of 25.49%, while PSCH experienced 23.19%.
Which ETF is bigger: BBP or PSCH?
As of March 11, 2026, BBP holds $50.55 M in assets under management (AUM), while PSCH manages $120.40 M.
What sectors do the BBP and PSCH ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.
What are the top holdings of the BBP ETF and PSCH ETF?
BBP top holdings include DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS. PSCH holds in its top three: ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS.
Which ETF is more diversified: BBP or PSCH?
BBP holds 63 securities with 30.11% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 43.5%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
